FACULTY SCHOLARSHIP
Publications
J. Roberts and Marcia Fosberg Distinguished Regents Professor of Pharmacotherapy and Director of the Drug Information Center Danial Baker published, “Drug utilization evaluation – asparaginase erwinia chrysanthemi (Recombinant) (Rylaze),” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in October 2021. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.
Pharmacotherapy Clinical Professor and Director of Quality Assurance Improvement & Accreditation Preparation Terri Levien and Danial Baker published, “Drug Utilization evaluation – belumosudil (Rezurock),” in the FMS in October 2021.
Danial Baker published, “Drug utilization evaluation – infigratinib (Truseltiq),” in the FMS in October 2021.
Drug Information Center Resident Regan Smith and Danial Baker published, “Drug utilization evaluation – finerenone (Kerendia),” in the FMS in October 2021.
Danial Baker published, “Drug utilization evaluation – belumosudil (Rezurock),” in the FMS in October 2021.
United States Transuranium and Uranium Registries (USTUR) Assistant Professor Maia Avtandilashvili and USTUR Director and Professor Sergei Tolmachev published, “Four-decade follow up of plutonium contaminated puncture wound treated with Ca-DTPA,” in the peer-reviewed Journal of Radiological Protection in December 2021.
USTUR Postdoctoral Research Associate Martin Šefl, Maia Avtandilashvili, and Sergei Tolmachev published, “Inhalation of soluble plutonium: 53-year follow-up of Manhattan Project worker,” in the peer-reviewed journal Health Physics in June 2021.
Martin Šefl, Maia Avtandilashvili, USTUR Associate in Research Stacey McComish, and Sergei Tolmachev published, “Plutonium in Manhattan Project workers: using autopsy data to evaluate organ content and dose estimates based on urine bioassay with implications for radiation epidemiology,” in the peer-reviewed journal PLOSONE in October 2021.
Maia Avtandilashvili and Sergei Tolmachev with three co-authors published, “Long-term retention of plutonium in the respiratory tracts of two acutely-exposed workers: estimation of bound fraction,” in the peer-reviewed journal Health Physics in March 2021.
Maia Avtandilashvili and Sergei Tolmachev with three co-authors published, “Modeling the long-term retention of plutonium in the human respiratory tract using scar-tissue compartments,” in the peer-reviewed journal Radiation Protection Dosimetry in November 2021.
Maia Avtandilashvili and Sergei Tolmachev with three co-authors published, “Modelling of long-term retention of high-fired plutonium oxide in the human respiratory tract: importance of scar-tissue compartments,” in the Journal of Radiological Protection.
Pharmaceutical Sciences Research Technologist Katherine D. Lynch, WSU Washington Animal Disease Diagnostic Lab Assistant Professor Laura A. White, and Pharmaceutical Sciences Assistant Professor John Clarke with three co-authors published, “MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period,” in Toxicology.
Pharmacotherapy Vice Chair and Allen I. White Distinguished Professor Joshua Neumiller and two co-authors published, “Overcoming barriers to implementing new therapies for diabetic kidney disease: lessons learned,” in Advances in Chronic Kidney Disease.
Josh Neumiller and two co-authors published, “Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals and recommendations,” in Postgraduate Medicine in November 2021.
Josh Neumiller and two co-authors published, “Determining the right agent for the right patient with type 2 diabetes and compelling comorbidities,” on PowerPak Online in November 2021.
Josh Neumiller and two co-authors published, “Adjusting background therapy when initiating GLP-1 receptor agonists: what pharmacists need to know,” on PowerPak Online in November 2021.
Josh Neumiller and two co-authors published, “Interchanging GLP-1 RAs: A roadmap for pharmacists,” on PowerPak Online in November 2021.
Josh Neumiller and two co-authors published, “GLP-1 receptor agonist news: late breaking data and pharmacist implications,” on PowerPak Online in November 2021.
Danial Baker published, “Drug evaluation – ruxolitinib cream (Opzelura),” in the FMS in December 2021.
Regan Smith and Danial Baker published, “Drug evaluation – atogepant (Qulipta),” in the FMS in December 2021.
Danial Baker published, “Drug evaluation – maralixibat (Livmarli),” in the FMS in December 2021.
Regan Smith, Terri Levien and Danial Baker published, “Drug evaluation – anifrolumab (Saphnelo) ,” in the FMS in December 2021.
Danial Baker published, “Drug utilization evaluation – atogepant (Qulipta),” in the FMS in December 2021.
Terri Levien and Danial Baker published, “Formulary drug review: belumosudil,” in Hospital Pharmacy in December 2021.
Presentations
Josh Neumiller presented “Clinical pearls about the use of SGLT2 inhibitors for patients with CKD,” at the American Society of Nephrology (ASN) Kidney Week 2021 annual conference on November 4, 2021.
Josh Neumiller presented “Optimal delivery of diabetes and CKD therapies by multidisciplinary care models,” at the ASN Kidney Week 2021 annual conference on November 4, 2021.
Danial Baker presented “Critical appraisal of systematic reviews,” at the Gulf Medical University’s College of Pharmacy in Ajman, United Arab Emirates on November 2, 2021.
Pharmacotherapy Academic Resident Lee Roy Esposo presented, “Legal shorts,” at the Washington State Pharmacy Association 2021 Technician Day on October 2, 2021.
Martin Šefl presented, “Internal dosimetry of plutonium: from biokinetics to dose estimates,” at Dny radiační ochrany 2021 (Days of Radiation Protection 2021), a virtual conference organized by the Czech Society for Radiation Protection, November 8, 2021. Faculty co-authors included Maia Avtandilashvili and Sergei Tolmachev.
Stacey McComish, USTUR Medical Technologist Florencio Martinez, and Sergei Tolmachev and two other co-authors created the presentation, “Over- and under-classification of underlying cause of death on death certificates from a small all-autopsied population of former nuclear workers,” which was presented virtually to the American Public Health Association Annual Meeting and Expo on October 22, 2021.
Josh Neumiller served as a panelist for the Pharmacy Times webcast, “Pharmacists and the effective management of patients with diabetes,” in December 2021.
Pharmacotherapy Assistant Professor Cheyenne Frazier and one other presented, “Caring for transgender people: insights and points of controversy in medication therapy,” at the American Society of Health-System Pharmacists Midyear Clinical Meeting on December 9, 2021.
Service
Pharmaceutical Sciences Professor Mary Paine has been selected as secretary/treasurer-elect for the International Society for the Study of Xenobiotics (ISSX). Dr. Paine will begin her term beginning January of 2022. ISSX has members from over forty-five different countries from both industry and academia and consist of research scientists or future scientists in toxicology, pharmacology, and molecular biology.
Pharmaceutical Sciences Associate Professor Sayed Daoud was recently appointed on National Institutes of Health (NIH) DP2 Editorial Board Review Panel.
Grants and Awards
Martin Šefl received an award from the Czech Society for Radiation Protection for the best work written by a young scientist in the field of radiation protection for his paper, “Inhalation of soluble plutonium: 53-year follow-up of Manhattan Project worker.”
STUDENT ACHIEVEMENT
Pharmaceutical Sciences and Molecular Medicine students
Shamema Nasrin (Lazarus lab) was selected as the Drug Metabolism and Disposition Highlighted Trainee Author for December 2021.
Doctor of Pharmacy (PharmD) students
Bahar Adamzadeh (class of 2022) with faculty co-authors Danial Baker and Terri Levien published, “Drug utilization evaluation – plasminogen, human-tvmh (Ryplazim),” in the FMS in October 2021.
Lynn Luu (class of 2022) and Bahar Adamzadeh (class of 2022) with faculty co-author Josh Neumiller published, “Update on the management of diabetic kidney disease,” in U.S. Pharmacist in November 2021.
Emily Hitt (class of 2022) published, “Acquiring research experience during pharmacy school,” about through the American Pharmacists Association website in November 2021.
Roselyn Johnson (class of 2022) with faculty co-authors Regan Smith, Terri Levien and Danial Baker published, “Drug evaluation – tick-borne encephalitis vaccine (TICOVAC),” in the FMS in December 2021.